Luna Innovations Incorporated (NASDAQ: LUNA) today announced its financial results for the third quarter and nine months ended September 30, 2013.
As compared to the same quarter last year, total revenue decreased by 16%, from $6.8 million in the third quarter of 2012 to $5.7 million in the third quarter of 2013. Revenues declined by 4% compared to the second quarter of 2013. Technology development revenues decreased by 15% compared to the third quarter of 2012, due primarily to the continued lower level of contract research projects within the company’s optical systems group. Technology development revenues grew 12% compared to the second quarter of 2013. Products and licensing revenues decreased $0.6 million, or 18%, compared to the third quarter of 2012 primarily resulting from sales of prototype shape sensing instruments in the third quarter of 2012 that did not recur in the third quarter of 2013. Gross profit decreased from $2.9 million for the third quarter of 2012 to $2.2 million for the third quarter of 2013. Operating expenses for the third quarter of 2013 decreased by $0.4 million, or 14%, from the third quarter of 2012.
The company reported a net loss attributable to common stockholders of $0.6 million, or $0.04 per diluted common share, for the third quarter of 2013, compared to a net loss of $0.3 million, or $0.02 per diluted common share, in the same quarter last year. Adjusted EBITDA, a non-GAAP measure, which is earnings before interest, taxes, and non-cash expenses of share-based compensation, depreciation, amortization and warrant expense, decreased to $(0.1) million for the third quarter of 2013, as compared to $0.5 million for the third quarter of 2012.
“We are pleased to see continued sequential growth in the government contracts segment of our business,” said My Chung, chief executive officer of Luna. “Softness in the sales of telecom products continued to adversely impact our overall results for the quarter. We remain keenly focused on the enhancement of our ODiSI platform for distributed strain and temperature sensing and our fiber optic shape sensing technology for minimally invasive medical applications to drive our growth in future quarters.”
Third Quarter Financial and Business Summary
- Total revenues decreased by 16%, from $6.8 million in the third quarter of 2012 to $5.7 million in the third quarter of 2013.
- Technology development revenues decreased by 15%, to $3.1 million, for the third quarter of 2013, from $3.7 million for the third quarter of 2012. Technology development revenues increased by 12% compared to the second quarter of 2013.
- Products and licensing revenue decreased by 18%, from $3.2 million in the third quarter of 2012 to $2.6 million in the third quarter of 2013.
- Gross profit for the third quarter of 2013 decreased to $2.2 million, or 39% of total revenues, from $2.9 million, or 42% of total revenues, for the third quarter of 2012.
- Selling, general and administrative expenses decreased by 14% to $2.2 million, or 39% of total revenues, for the third quarter of 2013, from $2.6 million, or 38% of total revenues, for the third quarter of 2012.
- Total operating expenses decreased to $2.8 million, or 49% of total revenues, for the third quarter of 2013 from $3.2 million, or 47% of total revenues for the third quarter of 2012.
- Adjusted EBITDA decreased to $(0.1) million in the third quarter 2013 from $0.5 million in the third quarter of 2012.
- Net loss attributable to common stockholders for the third quarter of 2013 increased to $0.6 million for the third quarter of 2013 from $0.3 million for the third quarter of 2012.
- Cash and cash equivalents totaled $8.2 million at September 30, 2013, as compared to $6.3 million at December 31, 2012 and $8.7 million at June 30, 2013.
Nine Months Ended September 30, 2013 Financial Summary
- Total revenue decreased by 20% to $16.2 million for the nine months ended September 30, 2013 compared to $20.2 million for the nine months ended September 30, 2012.
- Technology development revenues decreased by 26%, from $11.5 million for the nine months ended September 30, 2012 to $8.6 million for the nine months ended September 30, 2013.
- Products and licensing revenue decreased by 13%, from $8.7 million for the nine months ended September 30, 2012 to $7.6 million for the nine months ended September 30, 2013.
- Gross profit for the nine months ended September 30, 2013 decreased by 28%, to $6.0 million, compared to a gross profit of $8.3 million for the nine months ended September 30, 2012. Gross margin percentages decreased to 37% of revenues for the nine months ended September 30, 2013 from 41% of revenues for the nine months ended September 30, 2012.
- Selling, general and administrative expenses decreased 5% to $7.4 million, or 46% of total revenues for the nine months ended September 30, 2013 compared to $7.8 million, or 38% of total revenues for the nine months ended September 30, 2012.
- Total operating expenses decreased to $9.5 million, or 58% of total revenues, for the nine months ended September 30, 2013, from $9.7 million, or 48% of total revenues, for the nine months ended September 30, 2012.
- Adjusted EBITDA decreased to $(1.8) million for the nine months ended September 30, 2013 from $1.0 million for the nine months ended September 30, 2012.
- Net income attributable to common stockholders improved to $1.1 million for the nine months ended September 30, 2013, compared to a net loss attributable to common stockholders of $0.9 million for the nine months ended September 30, 2012, largely resulting from a net after-tax gain of $3.7 million realized on the sale of the company’s Secure Computing and Communications group for the nine months ended September 30, 2013.
Non-GAAP Measures
In evaluating the operating performance of its business, Luna’s management excludes certain charges and credits that are required by generally accepted accounting principles (“GAAP”). These non-GAAP results provide useful information to both management and investors by excluding items that the company believes may not be indicative of its operating performance, because either they are unusual and the company does not expect them to recur in the ordinary course of its business or they are unrelated to the ongoing operation of the business in the ordinary course. These non-GAAP measures should be considered in addition to results and guidance prepared in accordance with GAAP, but should not be considered a substitute for, or superior to, GAAP results. The non-GAAP measures included in this press release have been reconciled to the nearest GAAP measure in the table following the financial statements attached to this press release.
Conference Call Information
As previously announced, Luna will conduct an investor conference call at 5:00 p.m. (EST) today to discuss its financial results and business developments for the third quarter of 2013. The call can be accessed by dialing 866.318.8611 domestically or 617.399.5130 internationally prior to the start of the call. The participant access code is 37313561. Investors are advised to dial in at least five minutes prior to the call to register. The conference call will also be webcast live over the Internet. The webcast can be accessed by logging on to the “Investor Relations” section of the Luna website, www.lunainc.com, prior to the event. The webcast will be archived under the “Webcasts and Presentations” section of the Luna website for at least 30 days following the conference call.
About Luna:
Luna Innovations Incorporated (www.lunainc.com) is focused on sensing and instrumentation. Luna develops and manufactures new-generation products for the healthcare, telecommunications, energy and defense markets. The company’s products are used to measure, monitor, protect and improve critical processes in the markets it serves.
Forward-Looking Statements:
The statements in this release that are not historical facts constitute “forward-looking statements” made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. These statements include our expectations regarding the company’s future growth and commercialization of the company’s shape sensing platform. Management cautions the reader that these forward-looking statements are only predictions and are subject to a number of both known and unknown risks and uncertainties, and actual results, performance, and/or achievements of the company may differ materially from the future results, performance, and/or achievements expressed or implied by these forward-looking statements as a result of a number of factors. These factors include, without limitation, failure of demand for the company’s products and services to meet expectations, technological challenges and those risks and uncertainties set forth in the company’s periodic reports and other filings with the Securities and Exchange Commission. Such filings are available at the SEC’s website at www.sec.gov and at the company’s website at www.lunainc.com. The statements made in this release are based on information available to the company as of the date of this release and Luna undertakes no obligation to update any of the forward-looking statements after the date of this release.
| Luna Innovations Incorporated | ||||||||||||||||||||
| Condensed Consolidated Statements of Operations | ||||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||
| September 30, | September 30, | |||||||||||||||||||
| 2013 | 2012 | 2013 | 2012 | |||||||||||||||||
| (unaudited) | (unaudited) | |||||||||||||||||||
| Revenues: | ||||||||||||||||||||
| Technology development revenues | $ | 3,130,206 | $ | 3,691,154 | $ | 8,564,744 | $ | 11,528,700 | ||||||||||||
| Products and licensing revenues | 2,587,763 | 3,155,953 | 7,623,203 | 8,715,630 | ||||||||||||||||
| Total revenues | 5,717,969 | 6,847,107 | 16,187,947 | 20,244,330 | ||||||||||||||||
| Cost of revenues: | ||||||||||||||||||||
| Technology development costs | 2,282,061 | 2,646,293 | 6,663,194 | 8,074,595 | ||||||||||||||||
| Products and licensing costs | 1,228,134 | 1,307,285 | 3,516,196 | 3,821,980 | ||||||||||||||||
| Total cost of revenues | 3,510,195 | 3,953,578 | 10,179,390 | 11,896,575 | ||||||||||||||||
| Gross Profit | 2,207,774 | 2,893,529 | 6,008,557 | 8,347,755 | ||||||||||||||||
| Operating expense: | ||||||||||||||||||||
| Selling, general and administrative | 2,221,428 | 2,592,908 | 7,388,835 | 7,777,206 | ||||||||||||||||
| Research, development and engineering | 558,214 | 630,059 | 2,065,337 | 1,923,300 | ||||||||||||||||
| Total operating expense | 2,779,642 | 3,222,967 | 9,454,172 | 9,700,506 | ||||||||||||||||
| Operating loss | (571,868 | ) | (329,438 | ) | (3,445,615 | ) | (1,352,751 | ) | ||||||||||||
| Other income/(expense): | ||||||||||||||||||||
| Other (expenses)/income, net | (1,521 | ) | 37,866 | 85,289 | 85,083 | |||||||||||||||
| Interest expense | (42,654 | ) | (68,455 | ) | (150,732 | ) | (222,473 | ) | ||||||||||||
| Total other expense | (44,175 | ) | (30,589 | ) | (65,443 | ) | (137,390 | ) | ||||||||||||
| Loss from continuing operations before income taxes | (616,043 | ) | (360,027 | ) | (3,511,058 | ) | (1,490,141 | ) | ||||||||||||
| Income tax (benefit)/expense | (131,784 | ) | 15,618 | (1,087,839 | ) | 21,417 | ||||||||||||||
| Loss from continuing operations | (484,259 | ) | (375,645 | ) | (2,423,219 | ) | (1,511,558 | ) | ||||||||||||
| (Loss)/income from discontinued operations, net of income taxes | (129,653 | ) | 155,436 | 3,642,822 | 714,081 | |||||||||||||||
| Net (loss)/income | (613,912 | ) | (220,209 | ) | 1,219,603 | (797,477 | ) | |||||||||||||
| Preferred stock dividend | 26,166 | 34,095 | 76,161 | 94,974 | ||||||||||||||||
| Net (loss)/income attributable to common stockholders | $ | (640,078 | ) | $ | (254,304 | ) | $ | 1,143,442 | $ | (892,451 | ) | |||||||||
| Net loss per share from continuing operations: | ||||||||||||||||||||
| Basic | $ | (0.03 | ) | $ | (0.03 | ) | $ | (0.17 | ) | $ | (0.11 | ) | ||||||||
| Diluted | $ | (0.03 | ) | $ | (0.03 | ) | $ | (0.17 | ) | $ | (0.11 | ) | ||||||||
| Net (loss)/income per share from discontinued operations: | ||||||||||||||||||||
| Basic | $ | (0.01 | ) | $ | 0.01 | $ | 0.25 | $ | 0.05 | |||||||||||
| Diluted | $ | (0.01 | ) | $ | 0.01 | $ | 0.22 | $ | 0.04 | |||||||||||
| Net (loss)/income per share attributable to common stockholders: | ||||||||||||||||||||
| Basic | $ | (0.04 | ) | $ | (0.02 | ) | $ | 0.08 | $ | (0.06 | ) | |||||||||
| Diluted | $ | (0.04 | ) | $ | (0.02 | ) | $ | 0.07 | $ | (0.06 | ) | |||||||||
| Weighted average common shares and common equivalent shares outstanding: | ||||||||||||||||||||
| Basic | 14,441,707 | 13,939,938 | 14,285,829 | 13,903,809 | ||||||||||||||||
| Diluted | 14,441,707 | 16,312,622 | 16,593,102 | 16,269,306 | ||||||||||||||||
| Luna Innovations Incorporated | ||||||||||
| Condensed Consolidated Balance Sheets | ||||||||||
| September 30, | December 31, | |||||||||
| 2013 | 2012 | |||||||||
| (unaudited) | ||||||||||
| Assets | ||||||||||
| Current assets: | ||||||||||
| Cash and cash equivalents | $ | 8,184,665 | $ | 6,340,461 | ||||||
| Accounts receivable, net | 5,656,564 | 7,059,635 | ||||||||
| Inventory, net | 3,775,508 | 3,336,916 | ||||||||
| Prepaid expenses | 492,696 | 667,773 | ||||||||
| Other current assets | 70,208 | 35,629 | ||||||||
| Total current assets | 18,179,641 | 17,440,414 | ||||||||
| Property and equipment, net | 2,155,032 | 2,426,638 | ||||||||
| Intangible assets, net | 327,293 | 437,839 | ||||||||
| Other assets | 61,501 | 152,877 | ||||||||
| Total assets | $ | 20,723,467 | $ | 20,457,768 | ||||||
| Liabilities and stockholders’ equity | ||||||||||
| Liabilities: | ||||||||||
| Current Liabilities | ||||||||||
| Current portion of long term debt obligation | $ | 1,500,000 | $ | 1,500,000 | ||||||
| Current portion of capital lease obligation | 65,627 | 54,091 | ||||||||
| Accounts payable | 1,270,190 | 1,797,571 | ||||||||
| Accrued liabilities | 2,717,560 | 2,747,175 | ||||||||
| Deferred credits | 558,076 | 832,822 | ||||||||
| Total current liabilities | 6,111,453 | 6,931,659 | ||||||||
| Long-term debt obligation | 1,000,000 | 2,125,000 | ||||||||
| Long-term lease obligation | 127,337 | 128,917 | ||||||||
| Total liabilities | 7,238,790 | 9,185,576 | ||||||||
| Commitments and contingencies | ||||||||||
| Stockholders’ equity: | ||||||||||
| Preferred stock, par value $ 0.001, 1,321,514 shares authorized, issued and outstanding at September 30, 2013 and December 31, 2012 | 1,322 | 1,322 | ||||||||
| Common stock, par value $ 0.001, 100,000,000 shares authorized, 14,483,900 and 14,009,280 shares issued and outstanding at September 30, 2013 and December 31, 2012, respectively | 14,779 | 14,245 | ||||||||
| Additional paid-in capital | 62,430,014 | 61,361,505 | ||||||||
| Accumulated deficit | (48,961,438 | ) | (50,104,880 | ) | ||||||
| Total stockholders’ equity | 13,484,677 | 11,272,192 | ||||||||
| Total liabilities and stockholders’ equity | $ | 20,723,467 | $ | 20,457,768 | ||||||
| Luna Innovations Incorporated | ||||||||||
| Condensed Consolidated Statements of Cash Flows | ||||||||||
| Nine months ended | ||||||||||
| September 30, | ||||||||||
| 2013 | 2012 | |||||||||
| (unaudited) | ||||||||||
| Cash flows used in operating activities | ||||||||||
| Net income/(loss) | $ | 1,219,603 | $ | (797,477 | ) | |||||
| Adjustments to reconcile net income/(loss) to net cash used in operating activities | ||||||||||
| Depreciation and amortization | 711,375 | 814,498 | ||||||||
| Share-based compensation | 896,554 | 1,411,672 | ||||||||
| Warrant expense | — | 52,889 | ||||||||
| Gain on sale of discontinued operations, net of income taxes | (3,738,697 | ) | — | |||||||
| Allowance for doubtful accounts | 124,810 | — | ||||||||
| Tax benefit from utilization of net operating loss carryforward | (1,157,833 | ) | — | |||||||
| Change in assets and liabilities: | ||||||||||
| Accounts receivable | 1,880,545 | (1,771,022 | ) | |||||||
| Inventory | (438,592 | ) | (243,565 | ) | ||||||
| Other current assets | 26,931 | 107,826 | ||||||||
| Other assets | 91,376 | 56,375 | ||||||||
| Accounts payable and accrued expenses | (600,471 | ) | (36,216 | ) | ||||||
| Deferred credits | (274,746 | ) | (359,250 | ) | ||||||
| Net cash used in operating activities | (1,259,145 | ) | (764,270 | ) | ||||||
| Cash flows provided by/(used in) investing activities | ||||||||||
| Acquisition of property and equipment | (161,519 | ) | (242,396 | ) | ||||||
| Intangible property costs | (187,928 | ) | (131,727 | ) | ||||||
| Proceeds from sale of discontinued operations, net of fees | 4,522,460 | — | ||||||||
| Net cash provided by/(used in) investing activities | 4,173,013 | (374,123 | ) | |||||||
| Cash flows used in financing activities | ||||||||||
| Payments on capital lease obligations | (40,993 | ) | (37,924 | ) | ||||||
| Payment of debt obligations | (1,125,000 | ) | (1,125,000 | ) | ||||||
| Proceeds from the exercise of options and warrants | 96,329 | 84,501 | ||||||||
| Net cash used in financing activities | (1,069,664 | ) | (1,078,423 | ) | ||||||
| Net increase/(decrease) in cash or cash equivalents | 1,844,204 | (2,216,816 | ) | |||||||
| Cash and cash equivalents—beginning of period | 6,340,461 | 8,939,127 | ||||||||
| Cash and cash equivalents—end of period | $ | 8,184,665 | $ | 6,722,311 | ||||||
| Luna Innovations Incorporated | ||||||||||||||||||||
| Reconciliation of Net Income/(Loss) to EBITDA and Adjusted EBITDA | ||||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||
| September 30, | September 30, | |||||||||||||||||||
| 2013 | 2012 | 2013 | 2012 | |||||||||||||||||
| (unaudited) | (unaudited) | |||||||||||||||||||
| Net (loss)/income | $ | (613,912 | ) | $ | (220,209 | ) | $ | 1,219,603 | $ | (797,477 | ) | |||||||||
| Less (loss)/income from discontinued operations, net of income taxes | (129,653 | ) | 155,436 | 3,642,822 | 714,081 | |||||||||||||||
| Loss from continuing operations | (484,259 | ) | (375,645 | ) | (2,423,219 | ) | (1,511,558 | ) | ||||||||||||
| Interest expense | 42,654 | 68,455 | 150,732 | 222,473 | ||||||||||||||||
| Tax (benefit)/expense | (131,784 | ) | 15,618 | (1,087,839 | ) | 21,417 | ||||||||||||||
| Depreciation and amortization | 222,131 | 286,386 | 711,375 | 814,498 | ||||||||||||||||
| EBITDA | (351,258 | ) | (5,186 | ) | (2,648,951 | ) | (453,170 | ) | ||||||||||||
| Share-based compensation | 278,468 | 483,304 | 896,554 | 1,411,672 | ||||||||||||||||
| Warrant expense | — | 40,857 | — | 52,889 | ||||||||||||||||
| Adjusted EBITDA | $ | (72,790 | ) | $ | 518,975 | $ | (1,752,397 | ) | $ | 1,011,391 | ||||||||||
Contacts:
Investor Contact:
Dale
Messick, CFO
Phone: 1.540.769.8400
Email: IR@lunainc.com
